"HeLa Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays.
| Descriptor ID |
D006367
|
| MeSH Number(s) |
A11.251.210.190.400 A11.251.860.180.400 A11.436.340
|
| Concept/Terms |
HeLa Cells- HeLa Cells
- Cell, HeLa
- Cells, HeLa
- HeLa Cell
|
Below are MeSH descriptors whose meaning is more general than "HeLa Cells".
Below are MeSH descriptors whose meaning is more specific than "HeLa Cells".
This graph shows the total number of publications written about "HeLa Cells" by people in this website by year, and whether "HeLa Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 4 | 4 |
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 3 | 3 |
| 1998 | 0 | 6 | 6 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 6 | 6 |
| 2002 | 0 | 11 | 11 |
| 2003 | 0 | 4 | 4 |
| 2004 | 0 | 7 | 7 |
| 2005 | 0 | 7 | 7 |
| 2006 | 0 | 7 | 7 |
| 2007 | 0 | 4 | 4 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 7 | 7 |
| 2010 | 0 | 11 | 11 |
| 2011 | 0 | 6 | 6 |
| 2012 | 0 | 9 | 9 |
| 2013 | 0 | 5 | 5 |
| 2014 | 0 | 7 | 7 |
| 2015 | 0 | 7 | 7 |
| 2016 | 0 | 9 | 9 |
| 2017 | 0 | 5 | 5 |
| 2018 | 0 | 4 | 4 |
| 2019 | 0 | 10 | 10 |
| 2020 | 0 | 4 | 4 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HeLa Cells" by people in Profiles.
-
Quantitative Top-down Proteomics Revealed Kinase Inhibitor-Induced Proteoform-Level Changes in Cancer Cells. J Proteome Res. 2025 Jan 03; 24(1):303-314.
-
Discovery of Hippo signaling as a regulator of CSPG4 expression and as a therapeutic target for Clostridioides difficile disease. PLoS Pathog. 2023 03; 19(3):e1011272.
-
Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer. Sci Rep. 2022 01 19; 12(1):974.
-
A Small Step, a Giant Leap: Somatic Hypermutation of a Single Amino Acid Leads to Anti-La Autoreactivity. Int J Mol Sci. 2021 Nov 07; 22(21).
-
XRN2 interactome reveals its synthetic lethal relationship with PARP1 inhibition. Sci Rep. 2020 08 28; 10(1):14253.
-
Picoflow Liquid Chromatography-Mass Spectrometry for Ultrasensitive Bottom-Up Proteomics Using 2-µm-i.d. Open Tubular Columns. Anal Chem. 2020 04 07; 92(7):4711-4715.
-
Single-Probe Mass Spectrometry Analysis of Metabolites in Single Cells. Methods Mol Biol. 2020; 2064:61-71.
-
Proapoptotic Mitochondrial Carrier Homolog Protein PSAP Mediates Death Receptor 6 Induced Apoptosis. J Alzheimers Dis. 2020; 74(4):1097-1106.
-
Multivalent interaction of ESCO2 with the replication machinery is required for sister chromatid cohesion in vertebrates. Proc Natl Acad Sci U S A. 2020 01 14; 117(2):1081-1089.
-
VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway. Cancer Lett. 2020 02 01; 470:64-74.